Free Access
Med Sci (Paris)
Volume 20, Number 2, Février 2004
Page(s) 197 - 206
Section M/S revues
Published online 15 February 2004
  1. Abarcrombie M, Heaysman EM. Social behavior of cells in monolayering of fibroblasts. Exp Cell Res 1954; 6 : 293. [Google Scholar]
  2. Makowski L, Caspar DL, Phillips WC, Goodenough DA. Gap junction structures. II. Analysis of the X-ray diffraction data. J Cell Biol 1977; 74 : 629–45. [Google Scholar]
  3. Meda P. Connexines, canaux jonctionnels et communications cellulaires. Med Sci (Paris) 1996; 12 : 909–20. [Google Scholar]
  4. Willecke K, Eiberger J, Degen J, et al. Structural and functional diversity of connexin genes in the mouse and human genome. J Biol Chem 2002; 383 : 725–37. [Google Scholar]
  5. Mesnil M. Connexins and cancer. Biol Cell 2002; 94 : 493–500. [Google Scholar]
  6. Loewenstein WR. Junctional intercellular communication and the control of growth. Biochim Biophys Acta 1979; 560 : 1–65. [Google Scholar]
  7. Murray AW, Fitzgerald DJ. Tumor promoters inhibit metabolic cooperation in cocultures of epidermal and 3T3 cells. Biochem Biophys Res Comm 1979; 91 : 395–401. [Google Scholar]
  8. Yotti LP, Chang CC, Trosko JE. Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science 1979; 206 : 1089–91. [Google Scholar]
  9. Yamasaki H, Naus CCG. Role of connexin genes in growth control. Carcinogenesis 1996; 17 : 1199–213. [Google Scholar]
  10. Budunova IV, Williams GM. Cell culture assays for chemicals with tumor-promoting or tumor-inhibiting activity based on the modulation of intercellular communication. Cell Biol Toxicol 1994; 10 : 71–116. [Google Scholar]
  11. Paul DL. Molecular cloning of cDNA for rat liver gap junction protein. J Cell Biol 1986; 103 : 123–34. [Google Scholar]
  12. Beyer EC, Paul DL, Goodenough DA. Connexin 43 : a protein from rat heart homologous to a gap junction protein from liver. J Cell Biol 1987; 105 : 2621–9. [Google Scholar]
  13. Zhang JT, Nicholson BJ. Sequence and tissue distribution of a second protein of hepatic gap junctions, Cx26, as deduced from its cDNA. J Cell Biol 1989; 109 : 3391–401. [Google Scholar]
  14. Mesnil M, Krutovskikh V, Piccoli C, et al. Negative growth control of HeLa cells by connexin genes : connexin species specificity. Cancer Res 1995; 55 : 629–39. [Google Scholar]
  15. Bond SL, Bechberger JF, Khoo NK, Naus CCG. Transfection of C6 glioma cells with connexin 32 : the effects of expression of a nonendogenous gap junction protein. Cell Growth Differ 1994; 5 : 179–86. [Google Scholar]
  16. Princen F, Robe P, Gros D, et al. Rat gap junction connexin-30 inhibits proliferation of glioma cell lines. Carcinogenesis 2001; 22 : 507–13. [Google Scholar]
  17. Mesnil M, Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy : role of gap-junctional intercellular communication. Cancer Res 2000; 60 : 3989–99. [Google Scholar]
  18. Goldberg GS, Lampe PD, Sheedy D, Stewart CC, Nicholson BJ, Naus CCG. Direct isolation and analysis of endogenous transjunctional ADP from Cx43-transfected C6 glioma cells. Exp Cell Res 1998; 239 : 82–92. [Google Scholar]
  19. Saez JC, Connor JA, Spray DC, Bennett MVL. Hepatocyte gap junctions are permeable to the second messenger, inositol 1, 4, 5-triphosphate, and to calcium ions. Proc Natl Acad Sci USA 1989; 86 : 2708–12. [Google Scholar]
  20. Elfgang C, Eckert R, Lichtenberg-Fraté H, et al. Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol 1995; 129 : 805–17. [Google Scholar]
  21. Kumar NM, Gilula NB. The gap junction communication channel. Cell 1996; 84 : 381–8. [Google Scholar]
  22. Duflot-Dancer A, Mesnil M, Yamasaki H. Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes. Oncogene 1997; 15 : 2151–8. [Google Scholar]
  23. De Feijter AW, Matesic DF, Ruch RJ, Guan X, Chang CC, Trosko JE. Localization and function of the connexin 43 gap-junction protein in normal and various oncogene-expressing rat liver epithelial cells. Mol Carcinogen 1996; 16 : 203–12. [Google Scholar]
  24. Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, Boynton AL. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (Cx43). Cancer Res 1998; 58 : 5089–96. [Google Scholar]
  25. Hervé JC, Duthé F, Plaisance I, Bahbouhi B, Sarrouilhe D. The partner proteins of connexins on the track. Recent Res Dev Physiol 2003; 1 : 103–17. [Google Scholar]
  26. Trosko JE, Goodman JI. Intercellular communication may facilitate apoptosis : implications for tumor promotion. Mol Carcinogen 1994; 11 : 8–12. [Google Scholar]
  27. Chen SC, Pelletier DB, Ao P, Boynton AL. Connexin 43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases. Cell Growth Differ 1995; 6 : 681–90. [Google Scholar]
  28. Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA 1996; 93 : 1831–5. [Google Scholar]
  29. Klatzmann D, Valery CA, Bensimon G, et al. A phase I/II study of herpes simplex virus type1 thymidine kinase « suicide » gene therapy for recurrent glioblastoma. Study group on gene therapy for glioblastoma. Hum Gene Ther 1998; 9 : 2595–604. [Google Scholar]
  30. Ram Z, Culver KW, Oshiro EM, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med 1997; 3 : 1354–61. [Google Scholar]
  31. Mesnil M, Yamasaki H. La possibilité d’une thérapie génique antitumorale amplifiée par l’induction de la communication jonctionnelle intercellulaire. Med Sci (Paris) 1996; 12 : 1435–8. [Google Scholar]
  32. Huang RP, Hossain MZ, Huang R, Gano J, Fan Y, Boynton AL. Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human glioblastoma cells. Int J Cancer 2001; 92 : 130–8. [Google Scholar]
  33. King TJ, Fukushima LH, Hieber AD, Shimabukuro KA, Sakr WA, Bertram JS. Reduced levels of connexin 43 in cervical dysplasia: Inducible expression in a cervical carcinoma cell line decreases neoplastic potential with implications for tumor progression. Carcinogenesis 2000; 21 : 1097–109. [Google Scholar]
  34. Dubina MV, Iatckii NA, Popov DE, Vasiliev SV, Krutovskikh VA. Connexin 43, but not connexin 32, is mutated at advanced stages of human sporadic colon cancer. Oncogene 2002; 21 : 4992–6. [Google Scholar]
  35. Krutovskikh V, Mazzoleni G, Mironov N, et al. Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int J Cancer 1994; 56 : 87–94. [Google Scholar]
  36. Schneider B, Teschner M, Sudermann T, Pikula B, Lautermann J. Expression of gap junction proteins (connexin 26, 30, 32, 43) in normal mucosa, hyperkeratosis and carcinoma of the human larynx. J Otorhinolaryngol Relat Spec 2002; 64 : 324–9. [Google Scholar]
  37. Mehta PP, Perez-Stable C, Nadji M, Mian M, Asotra K, Roos BA. Suppression of human prostate cancer cell growth by forced expression of connexin genes. Dev Genet 1999; 24 : 91–110. [Google Scholar]
  38. Habermann H, Ray V, Habermann W, Prins GS. Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer. J Urol 2002; 167 : 655–60. [Google Scholar]
  39. Laird DW, Fistouris P, Batist G, et al. Deficiency of connexin 43 gap junctions is an independent marker for breast tumors. Cancer Res 1999; 59 : 4104–10. [Google Scholar]
  40. Al Moustafa AE, Alaoui-Jamali MA, Batist G, et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002; 21 : 2634–40. [Google Scholar]
  41. Krutovskikh VA, Piccoli C, Yamasaki H. Gap junction intercellular communication propagates cell death in cancerous cells. Oncogene 2002; 27 : 1989–99. [Google Scholar]
  42. Park JY, Elshami AA, Amin K, Rizk N, Kaiser LR, Albelda SM. Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy. Gene Ther 1997; 4 : 909–17. [Google Scholar]
  43. Touraine RL, Ishii-Morita H, Ramsey WJ, Blaese RM. The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communication. Gene Ther 1998; 5 : 1705–11. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.